• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用制剂方法改变油性肠胃外给药贮库的体外药物释放速率。

Modification of in vitro drug release rate from oily parenteral depots using a formulation approach.

作者信息

Fredholt K, Larsen D H, Larsen C

机构信息

Department of Analytical and Pharmaceutical Chemistry, The Royal Danish School of Pharmacy, Universitetsparken 2, DK-2100, Copenhagen, Denmark.

出版信息

Eur J Pharm Sci. 2000 Sep;11(3):231-7. doi: 10.1016/s0928-0987(00)00104-4.

DOI:10.1016/s0928-0987(00)00104-4
PMID:11042229
Abstract

Rate constants for transfer of naproxen and lidocaine from different oils and oil mixtures to aqueous buffer, pH 6.00, were determined using the rotating dialysis cell. Significantly different first-order rate constants related to attainment of equilibrium, k(obs), were derived depending on the type of oil/oil mixtures used in the release experiments. For the drugs a linear correlation was found between logk(obs) and the logarithm of the partition coefficient P(app): logk(obs)=-0.68 logP(app)-0.25 (k(obs) in h(-1), n=26). A linear relationship was observed between the calculated and experimentally determined P(app) values for the oil mixtures investigated. The specific rate constants, k(ow) and k(wo), related to the partition process were derived from the determined k(obs) and P(app) values. The rate constant k(ow) representing the rate of transfer of the solute from the oil phase to the aqueous buffer was shown to be strongly dependent on the partition coefficient according to the relationship: logk(ow)=-0.68 logP(app)-log(P(app)+1)-0.25 (k(ow) in h(-1), n=26). In particular, diminished release rates were seen for oil mixtures containing castor oil most likely afforded by hydrogen bonding between the solute and the hydroxy groups of the latter vegetable oil. In this study it has been possible to alter P(app) for a specific compound up to a factor of 10 by variation of the composition of the oil vehicle. Such a span of P(app) values results in in vitro release rates differing a factor of 37. Thus, by proper design of the oil vehicle composition it should be possible to modify the release rate for a specific compound within certain limits.

摘要

使用旋转透析池测定了萘普生和利多卡因从不同油类及油混合物转移至pH 6.00的水性缓冲液中的速率常数。根据释放实验中所用油类/油混合物的类型,得出了与达到平衡相关的显著不同的一级速率常数k(obs)。对于这些药物,发现logk(obs)与分配系数P(app)的对数之间存在线性关系:logk(obs)= -0.68 logP(app) - 0.25(k(obs)单位为h⁻¹,n = 26)。在所研究的油混合物的计算P(app)值与实验测定的P(app)值之间观察到线性关系。与分配过程相关的特定速率常数k(ow)和k(wo)由所测定的k(obs)和P(app)值得出。代表溶质从油相转移至水性缓冲液速率的速率常数k(ow)根据以下关系显示出强烈依赖于分配系数:logk(ow)= -0.68 logP(app) - log(P(app) + 1) - 0.25(k(ow)单位为h⁻¹,n = 26)。特别地,对于含有蓖麻油的油混合物,观察到释放速率降低,这很可能是由于溶质与后一种植物油的羟基之间形成氢键所致。在本研究中,通过改变油载体的组成,有可能将特定化合物的P(app)改变高达10倍。这样的P(app)值跨度导致体外释放速率相差37倍。因此,通过合理设计油载体组成,应该有可能在一定限度内改变特定化合物的释放速率。

相似文献

1
Modification of in vitro drug release rate from oily parenteral depots using a formulation approach.采用制剂方法改变油性肠胃外给药贮库的体外药物释放速率。
Eur J Pharm Sci. 2000 Sep;11(3):231-7. doi: 10.1016/s0928-0987(00)00104-4.
2
Assessment of rate of drug release from oil vehicle using a rotating dialysis cell.使用旋转透析池评估油载体中药物的释放速率。
Eur J Pharm Sci. 2000 Sep;11(3):223-9. doi: 10.1016/s0928-0987(00)00105-6.
3
Addition of hydrogen bond donating excipients to oil solution: effect on in vitro drug release rate and viscosity.向油溶液中添加供氢键形成的辅料:对体外药物释放速率和粘度的影响。
Eur J Pharm Sci. 2001 Jul;13(4):403-10. doi: 10.1016/s0928-0987(01)00136-1.
4
Effect of drug lipophilicity on in vitro release rate from oil vehicles using nicotinic acid esters as model prodrug derivatives.
Int J Pharm. 2001 Mar 23;216(1-2):83-93. doi: 10.1016/s0378-5173(01)00568-3.
5
In vitro assessment of drug release rates from oil depot formulations intended for intra-articular administration.用于关节内给药的油库制剂药物释放速率的体外评估。
Eur J Pharm Sci. 2006 Dec;29(5):348-54. doi: 10.1016/j.ejps.2006.07.002. Epub 2006 Jul 14.
6
Characteristics of drug substances in oily solutions. Drug release rate, partitioning and solubility.
Int J Pharm. 2002 Jan 31;232(1-2):107-17. doi: 10.1016/s0378-5173(01)00904-8.
7
In vitro assessment of lidocaine release from aqueous and oil solutions and from preformed and in situ formed aqueous and oil suspensions. Parenteral depots for intra-articular administration.利多卡因从水性溶液、油性溶液以及预制和原位形成的水性和油性混悬液中的体外释放评估。用于关节内给药的胃肠外贮库。
Drug Deliv. 2008 Jan;15(1):23-30. doi: 10.1080/10717540701828657.
8
Effect of oil phase lipophilicity on in vitro drug release from o/w microemulsions with low surfactant content.油相亲脂性对低表面活性剂含量的水包油型微乳剂体外药物释放的影响。
Drug Dev Ind Pharm. 2006 Jun;32(5):539-48. doi: 10.1080/03639040600599806.
9
Assessment of drug release from oil depot formulations using an in vitro model -- potential applicability in accelerated release testing.使用体外模型评估油库制剂的药物释放——在加速释放测试中的潜在适用性。
Drug Dev Ind Pharm. 2008 Mar;34(3):297-304. doi: 10.1080/03639040701655994.
10
Prolonged naproxen joint residence time after intra-articular injection of lipophilic solutions comprising a naproxen glycolamide ester prodrug in the rat.关节内注射包含亲脂性溶液的萘普生二醇酰胺酯前药后,大鼠的萘普生关节驻留时间延长。
Int J Pharm. 2013 Jul 15;451(1-2):34-40. doi: 10.1016/j.ijpharm.2013.04.056. Epub 2013 Apr 26.

引用本文的文献

1
An injectable oleogel-based bupivacaine formulation for prolonged non-opioid post-operative analgesia.一种用于延长非阿片类术后镇痛的基于油凝胶的注射用布比卡因制剂。
Drug Deliv Transl Res. 2025 Apr;15(4):1424-1443. doi: 10.1007/s13346-024-01688-6. Epub 2024 Aug 6.
2
Long-acting intramuscular injections of ELQ-331, an antimalarial agent.长效肌肉注射抗疟药ELQ-331。
Eur J Pharm Sci. 2024 Jul 1;198:106795. doi: 10.1016/j.ejps.2024.106795. Epub 2024 May 8.
3
Preparation of an oil suspension containing ondansetron hydrochloride as a sustained release parenteral formulation.
制备盐酸昂丹司琼油混悬注射液作为一种缓释型注射剂。
Drug Deliv Transl Res. 2020 Feb;10(1):282-295. doi: 10.1007/s13346-019-00687-2.
4
From micro- to nanostructured implantable device for local anesthetic delivery.从用于局部麻醉药递送的微结构到纳米结构可植入装置
Int J Nanomedicine. 2016 Jun 8;11:2695-709. doi: 10.2147/IJN.S99028. eCollection 2016.
5
Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.长效注射疗法的优势、劣势、机遇与挑战:对其在HIV治疗中应用的见解
Adv Drug Deliv Rev. 2016 Aug 1;103:144-156. doi: 10.1016/j.addr.2016.02.003. Epub 2016 Feb 23.
6
Accelerated in-vitro release testing methods for extended-release parenteral dosage forms.加速释放体外测试方法用于延长释放型肠外剂型。
J Pharm Pharmacol. 2012 Jul;64(7):986-96. doi: 10.1111/j.2042-7158.2012.01482.x. Epub 2012 Mar 8.
7
Critical factors influencing the in vivo performance of long-acting lipophilic solutions--impact on in vitro release method design.影响长效亲脂性溶液体内性能的关键因素——对体外释放方法设计的影响。
AAPS J. 2009 Dec;11(4):762-70. doi: 10.1208/s12248-009-9153-9. Epub 2009 Nov 6.
8
In silico prediction of drug permeability across buccal mucosa.经计算机模拟预测药物透过颊黏膜的渗透性。
Pharm Res. 2009 May;26(5):1130-9. doi: 10.1007/s11095-009-9831-4. Epub 2009 Jan 30.
9
Effect of drug lipophilicity and ionization on permeability across the buccal mucosa: a technical note.药物亲脂性和离子化对颊黏膜渗透的影响:技术说明
AAPS PharmSciTech. 2008;9(2):501-4. doi: 10.1208/s12249-008-9071-7. Epub 2008 Mar 20.
10
In situ-forming oleogel implant for rivastigmine delivery.用于递送卡巴拉汀的原位形成油凝胶植入剂。
Pharm Res. 2008 Apr;25(4):845-52. doi: 10.1007/s11095-007-9384-3. Epub 2007 Aug 12.